Literature DB >> 3093111

Disposition of the naturally occurring antimutagenic plant phenol, ellagic acid, and its synthetic derivatives, 3-O-decylellagic acid and 3,3'-di-O-methylellagic acid in mice.

R C Smart, M T Huang, R L Chang, J M Sayer, D M Jerina, A H Conney.   

Abstract

The effect of ellagic acid and some of its more lipophilic derivatives on the mutagenicity of (+/-)-7 beta,8 alpha-dihydroxy-9 alpha,10 alpha-epoxy-7,8,9,10-tetrahydrobenz[a]pyrene was examined in Salmonella typhimurium TA100. Ellagic acid, 3,3'-di-O-methylellagic acid, 4,4'-di-O-methylellagic acid and 3-O-decylellagic acid were found to have approximately equal antimutagenic activity. The tissue distribution and elimination of ellagic acid, 3,3'-di-O-methylellagic acid and 3-O-decylellagic acid were examined in CD-1 mice. Little or no ellagic acid (less than 1 nmol/g) was found in blood, lung or liver after the oral administration by gavage of 300 mumol of ellagic acid per kg body weight of after feeding 1% of ellagic acid in the diet for 1 week. Following the i.p. administration of 120 mumol/kg of ellagic acid, the blood and lung levels of ellagic acid were 15-20 nmol/g at 30 min after the dose, and the concentrations of ellagic acid decreased to 1-3 nmol/g at 6-8 h after the dose. A portion of the administered i.p. dose precipitated in the abdominal cavity. After i.v. administration, ellagic acid was eliminated very rapidly from blood, lung and liver, and approximately 70% of the administered dose was recovered in the urine and feces as free ellagic acid and its conjugates. At 2 h after an i.v. injection of 60 mumol/kg of ellagic acid, 46% of the dose was recovered in the urine as ellagic acid and its conjugates. Of this amount, about half was excreted as free ellagic acid and half was excreted as conjugates. An additional 25% of the dose was recovered in the feces (mostly as free ellagic acid) after 7 h. The disposition of 3,3'-di-O-methylellagic acid or 3-O-decylellagic acid after i.v. administration (32 mumol/kg) was examined and compared to the disposition of the same i.v. dose of ellagic acid. The concentrations of ellagic acid, 3,3'-di-O-methylellagic acid and 3-O-decylellagic acid decreased rapidly in the blood, liver and lung, but the concentrations of 3-O-decylellagic acid in the lung throughout the experimental period (2-360 min) was on average 20- to 40-fold higher than the corresponding average concentrations of ellagic acid or 3,3'-di-O-methylellagic acid.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3093111     DOI: 10.1093/carcin/7.10.1663

Source DB:  PubMed          Journal:  Carcinogenesis        ISSN: 0143-3334            Impact factor:   4.944


  9 in total

1.  Enhanced activity of punicalagin delivered via polymeric implants against benzo[a]pyrene-induced DNA adducts.

Authors:  Farrukh Aqil; Manicka V Vadhanam; Ramesh C Gupta
Journal:  Mutat Res       Date:  2012-01-05       Impact factor: 2.433

2.  The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans.

Authors:  Begoña Cerdá; Juan Carlos Espín; Soledad Parra; Pedro Martínez; Francisco A Tomás-Barberán
Journal:  Eur J Nutr       Date:  2004-01-06       Impact factor: 5.614

3.  Triphala and its active constituent chebulinic acid are natural inhibitors of vascular endothelial growth factor-a mediated angiogenesis.

Authors:  Kai Lu; Debanjan Chakroborty; Chandrani Sarkar; Tingting Lu; Zhiliang Xie; Zhongfa Liu; Sujit Basu
Journal:  PLoS One       Date:  2012-08-24       Impact factor: 3.240

4.  Nanoencapsulation of pomegranate bioactive compounds for breast cancer chemoprevention.

Authors:  Amit B Shirode; Dhruba J Bharali; Sameera Nallanthighal; Justin K Coon; Shaker A Mousa; Ramune Reliene
Journal:  Int J Nanomedicine       Date:  2015-01-09

5.  Inhibitory effect of ellagic acid on N-2-fluorenylacetamide-induced liver carcinogenesis in male ACI/N rats.

Authors:  T Tanaka; H Iwata; K Niwa; Y Mori; H Mori
Journal:  Jpn J Cancer Res       Date:  1988-12

6.  Preparation of β-CD-Ellagic Acid Microspheres and Their Effects on HepG2 Cell Proliferation.

Authors:  Hongkai Wang; Yingxia Zhang; Zhongjing Tian; Jing Ma; Meiling Kang; Chengshi Ding; Dongfeng Ming
Journal:  Molecules       Date:  2017-12-08       Impact factor: 4.411

Review 7.  Ellagic Acid: A Review on Its Natural Sources, Chemical Stability, and Therapeutic Potential.

Authors:  Javad Sharifi-Rad; Cristina Quispe; Carla Marina Salgado Castillo; Rodrigo Caroca; Marco A Lazo-Vélez; Halyna Antonyak; Alexandr Polishchuk; Roman Lysiuk; Petro Oliinyk; Luigi De Masi; Paola Bontempo; Miquel Martorell; Sevgi Durna Daştan; Daniela Rigano; Michael Wink; William C Cho
Journal:  Oxid Med Cell Longev       Date:  2022-02-21       Impact factor: 6.543

8.  Dietary berries and ellagic acid prevent oxidative DNA damage and modulate expression of DNA repair genes.

Authors:  Harini S Aiyer; Manicka V Vadhanam; Radka Stoyanova; Gerard D Caprio; Margie L Clapper; Ramesh C Gupta
Journal:  Int J Mol Sci       Date:  2008-03-12       Impact factor: 6.208

9.  Investigation of the biological and anti-cancer properties of ellagic acid-encapsulated nano-sized metalla-cages.

Authors:  Abhishek Dubey; Dae Won Park; Jung Eun Kwon; Yong Joon Jeong; Taegeun Kim; Inhye Kim; Se Chan Kang; Ki-Whan Chi
Journal:  Int J Nanomedicine       Date:  2015-09-02
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.